Mohammad Gad, MD
Internal Medicine · Indianapolis, INNPI 1801891692
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,865 of the $3,038 with a category attached, or 61.4%. 10 manufacturers reported payments, led by Medtronic at 47.8% of the total.
Across 32 payments — averaging $94.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Philips North America LLC$870
- Biosense Webster, Inc.$542
- AstraZeneca$50
- Johnson & Johnson$35
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$26
- plus $63 from 4 others
What the payments were for
- Travel & lodging$1,86561%
- Food & beverage$1,17339%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 13 | $1,451 |
| Philips North America LLC | 6 | $870 |
| Biosense Webster, Inc. | 1 | $542 |
| AstraZeneca | 4 | $50 |
| Johnson & Johnson | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Novartis | 1 | $21 |
| GE HealthCare | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$896
- Carto 3$542
- (9520) IGT Devices Undivided$452
- (9124) LM Undivided$249
How this compares
$3,038 in reported general payments places this provider in the 85th percentile of 1,747 internal medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 12 | $99 |
| Pantoprazole Sodium | 14 | $86 |
| Atorvastatin Calcium | 18 | $70 |
| Famotidine | 14 | $59 |
| Amlodipine Besylate | 18 | $49 |
| Metoprolol Tartrate | 12 | $44 |
| Ropinirole Hcl | 12 | $43 |
| Furosemide | 15 | $32 |
| Prednisone | 14 | $13 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Indianapolis
- Raj VuppalanchiIndianapolis$279K
- Napoleon MamintaIndianapolis$116K
- Allon FriedmanIndianapolis$111K
- John AyresIndianapolis$107K
- Awaneesh KumarIndianapolis$68K
- Justin FieldIndianapolis$49K
- Misty ShieldsIndianapolis$39K
- Volodymyr OliynykIndianapolis$38K
- Sapan BhutaIndianapolis$30K
- Azizullah BeranIndianapolis$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.